Trials / Completed
CompletedNCT03618797
A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia
A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin Versus Pitavastatin/Fenofibrate in Complex-dyslipidemia Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 347 (actual)
- Sponsor
- Hanlim Pharm. Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Pitavastatin versus Pitavastatin/Fenofibrate in complex-dyslipidemia patients.
Detailed description
The purpose of this study is to demonstrate the efficacy of the Pitavastatin/Fenofibrate in complex-dyslipidemia patients by the reduction of non-HDL-Cholesterol levels compared with Pitavastatin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HL-PIF cap.160/2mg + Placebo | Fenofibrate pellet (as micronized fenofibrate 160mg) and Pitavastatin Ca 2mg |
| DRUG | Livalo tab. 2mg + Placebo | Pitavastatin ca 2mg |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2018-01-01
- Completion
- 2018-05-01
- First posted
- 2018-08-07
- Last updated
- 2018-08-07
Source: ClinicalTrials.gov record NCT03618797. Inclusion in this directory is not an endorsement.